The letter, written by Australian researchers Deborah Williamson, M.D., Ph.D., Benjamin Howden, M.D., PhD. and Timothy Stinear, Ph.D., addressed the recent spread of nontuberculous mycobacteria (NTM) infections related to heating-cooling units such as the Stockert 3T heater-cooler system and others used during open-heart surgeries.
"Our observations highlight the potential for global dissemination of contaminated medical devices, including to regions such as Australia and New Zealand," the authors wrote.
The Stockert 3T heater-cooler system, which helps regulate a patient's body temperature during surgery, has been linked to infection during certain surgeries.
The Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) have each issued Stockert 3T infection reports specifically involving M. chimaera, a bacterial infection.
"Infections have been publicly reported in five countries, and it has been noted that these infections developed after the Stockert 3T heating and cooling unit manufactured by Sorin Group Deutschland (now LivaNova) had been used to regulate the body temperature of patients during coronary-artery bypass grafting," wrote the authors.
READ MORE STOCKERT 3T LEGAL NEWS
Between May 2015 and July 2016, a total of 48 presumptive M. chimaera isolates, which can lead to infection, were obtained. The tests found that 43 were from Stockert 3T heating and cooling units and 5 were from patient samples, according to the editorial letter.
The Melbourne researchers closed the letter with a call for public sharing of research data for the sake of the public health:
"These data show the value of combining high-resolution molecular analysis and public sharing of sequence data to improve responses to outbreaks that have potential public health importance."